Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 7;9(9):1178.
doi: 10.3390/biomedicines9091178.

Autophagy, Mesenchymal Stem Cell Differentiation, and Secretion

Affiliations
Review

Autophagy, Mesenchymal Stem Cell Differentiation, and Secretion

Mikhail Menshikov et al. Biomedicines. .

Abstract

Mesenchymal stem cells (MSC) are multipotent cells capable to differentiate into adipogenic, osteogenic, and chondrogenic directions, possessing immunomodulatory activity and a capability to stimulate angiogenesis. A scope of these features and capabilities makes MSC a significant factor of tissue homeostasis and repair. Among factors determining the fate of MSC, a prominent place belongs to autophagy, which is activated under different conditions including cell starvation, inflammation, oxidative stress, and some others. In addition to supporting cell homeostasis by elimination of protein aggregates, and non-functional and damaged proteins, autophagy is a necessary factor of change in cell phenotype on the process of cell differentiation. In present review, some mechanisms providing participation of autophagy in cell differentiation are discussed.

Keywords: autophagy; differentiation; immunomodulation; mesenchymal stem cells; signal transduction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Autophagy signaling. The inhibition of mTORC1 by Rapamycin or AMPK abolishes mTORC1-dependent suppression of ULK1/2 activity and thereby triggers autophagy. Activation of VPS34 results in synthesis of PI3P necessary for phagophore formation. ATG12 and LC3 conjugation systems are involved in elongation and closure of autophagosome membrane. SQSTM1 as well other autophagy receptors, transfer polyubiquitilated cargo into autophagosome. Autophagosome fuses with lysosome following by degradation of content with lysosomal enzymes. Abbreviations used: ULK, Unk-51 autophagy activating kinase; FIP-200, FAK family kinase interacting protein of 200 kDa; BCN1, Beclin 1; VPS34, vacuolar protein sorting 34, class III PI3 kinase; SQSTM1, sequestosome 1; LC3, microtubule-associated proteins 1A/1B light chain 3B.
Figure 2
Figure 2
Relationship between autophagy and intracellular signaling participating in MSC differentiation. (A) adipogenesis transcription factor C/EBPβ activates proteinase ATG4b, which induces LC3 maturation. LC3II binds factors Klf 2/3 and transfers them into autolysosome, thereby eliminating PPARγ suppression by Klfs [69]. (B) LC3II and SQSTM1 perform autolysosomal degradation of Disheveled (Dvl) and β-catenin. This effect antagonizes SQSTM1 suppression by Wnt/β-catenin signaling [71,72]. (C) autophagy is a necessary factor of MSC differentiation; Wnt and Notch weaken adipogenesis and reinforce osteogenesis. The existence of selective relationships between autophagy and cell signaling creates an opportunity to regulate efficiency of MSC differentiation as a factor of tissue repair.

References

    1. Mazo M.M., Planat-Bénard V., Abizanda G., Pelacho B., Léobon B., Gavira J.J., Penuelas I., Cemborain A., Penicaud L., Laharrague P., et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur. J. Heart Fail. 2008;10:454–462. doi: 10.1016/j.ejheart.2008.03.017. - DOI - PubMed
    1. Wollert K.C., Drexler H. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat. Rev. Cardiol. 2010;7:204–215. doi: 10.1038/nrcardio.2010.1. - DOI - PubMed
    1. Guzzo R.M., Gibson J., Xu R.-H., Lee F.Y., Drissi H. Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. J. Cell. Biochem. 2012;114:480–490. doi: 10.1002/jcb.24388. - DOI - PubMed
    1. Gao W.-X., Sun Y.-Q., Shi J., Li C.-L., Fang S.-B., Wang D., Deng X.-Q., Wen W., Fu Q.-L. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells. Stem Cell Res. Ther. 2017;8:48. doi: 10.1186/s13287-017-0499-0. - DOI - PMC - PubMed
    1. Kusuma G.D., Carthew J.R., Lim R., Frith J.E. Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect. Stem Cells Dev. 2017;26:617–631. doi: 10.1089/scd.2016.0349. - DOI - PubMed

LinkOut - more resources